Article
Genetic risk assessment for hereditary renal cell carcinoma: Clinical consensus statement
3 Aug 2021
Abstract excerpt
BACKGROUND: Although renal cell carcinoma (RCC) is believed to have a strong hereditary component, there is a paucity of published guidelines for genetic risk assessment. A panel of experts was convened to gauge current opinions. METHODS: A North American multidisciplinary panel with expertise in hereditary RCC, including urologists, medical oncologists, clinical geneticists, genetic counselors, and patient...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
